Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An update from Hofseth Biocare ASA ( (HOFBF) ) is now available.
Hofseth BioCare ASA reported a decline in total operating revenues for Q2 2025 compared to the previous year, with a negative EBITDA. However, the company saw a significant increase in Human Nutrition B2B sales and launched new products, marking milestones in its human nutrition franchise. The company continues to expand its global presence with new distribution agreements and product awards, reinforcing its market position in health and wellness.
More about Hofseth Biocare ASA
Hofseth BioCare ASA (HBC) is a Norwegian company focused on consumer and pet health, emphasizing sustainability and optimal resource utilization. The company upcycles salmon industry by-products into health-improving ingredients such as ProGo®, OmeGo®, and CalGo® for human and pet health. HBC is committed to scientific research, leading to partnerships and patents, and has expanded into biotech with a focus on cancer and asthma therapies.
Average Trading Volume: 94,400
Current Market Cap: NOK737.9M
Learn more about HOFBF stock on TipRanks’ Stock Analysis page.